First Time Loading...

Reata Pharmaceuticals Inc
NASDAQ:RETA

Watchlist Manager
Reata Pharmaceuticals Inc Logo
Reata Pharmaceuticals Inc
NASDAQ:RETA
Watchlist
Price: 172.36 USD Market Closed
Updated: May 1, 2024

Reata Pharmaceuticals Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Reata Pharmaceuticals Inc
Cash from Operating Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Reata Pharmaceuticals Inc
NASDAQ:RETA
Cash from Operating Activities
-$248.3m
CAGR 3-Years
17%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Operating Activities
$22.8B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Operating Activities
$13.9B
CAGR 3-Years
0%
CAGR 5-Years
18%
CAGR 10-Years
15%
Pfizer Inc
NYSE:PFE
Cash from Operating Activities
$8.7B
CAGR 3-Years
-15%
CAGR 5-Years
-11%
CAGR 10-Years
-7%
Merck & Co Inc
NYSE:MRK
Cash from Operating Activities
$13B
CAGR 3-Years
8%
CAGR 5-Years
4%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Cash from Operating Activities
$4.2B
CAGR 3-Years
-13%
CAGR 5-Years
-5%
CAGR 10-Years
-3%

See Also

What is Reata Pharmaceuticals Inc's Cash from Operating Activities?
Cash from Operating Activities
-248.3m USD

Based on the financial report for Jun 30, 2023, Reata Pharmaceuticals Inc's Cash from Operating Activities amounts to -248.3m USD.

What is Reata Pharmaceuticals Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-22%

Over the last year, the Cash from Operating Activities growth was 9%. The average annual Cash from Operating Activities growth rates for Reata Pharmaceuticals Inc have been 17% over the past three years , -22% over the past five years .